Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Taxes × Clear all

Sponsor

Conditions

Breast Neoplasms 47 Fallopian Tube Neoplasms 22 Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 17 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 11 Breast Neoplasms, Male 11 Lung Neoplasms 9 Brenner Tumor 9 Inflammatory Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Melanoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Adenocarcinoma Of Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Pleural Effusion, Malignant 3 Endometrial Adenocarcinoma 3 Cholangiocarcinoma 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Thymoma 2 Pancreatic Adenocarcinoma 2 Neurotoxicity Syndromes 2 Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2 Brain Neoplasms 2

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡